Anna N. Tevyashova
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 8
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 8
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis 8
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation 8
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility 8
-
- Cancer therapeutics and mechanisms 16
- DNA and Nucleic Acid Chemistry 5
- RNA and protein synthesis mechanisms 5
- Co-authors
- Eugenia N. OlsufyevaM. N. PreobrazhenskayaАlexander А. ShtilElena P. MirchinkElena B. IsakovaSvetlana E. SolovievaLyubov G. DezhenkovaAndrey E. Shchekotikhin
- Journals
- PLoS ONE (2 papers)International Journal of Molecular Sciences (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- RussiaUnited KingdomGermany
In The Last Decade
Anna N. Tevyashova
47 papers receiving 562 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 70
- Toxicology 34
- Pharmacology 160
- Organic Chemistry 230
- Infectious Diseases 148
Countries citing papers authored by Anna N. Tevyashova
This map shows the geographic impact of Anna N. Tevyashova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna N. Tevyashova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna N. Tevyashova more than expected).
Fields of papers citing papers by Anna N. Tevyashova
This network shows the impact of papers produced by Anna N. Tevyashova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna N. Tevyashova. The network helps show where Anna N. Tevyashova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna N. Tevyashova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 2 | |
| 9 | 2017 | 23 | |
| 10 | 2016 | 7 | |
| 11 | 2016 | 23 | |
| 12 | 2011 | 24 | |
| 13 | 2010 | 5 | |
| 14 | 2010 | 4 | |
| 15 | 2009 | 17 | |
| 16 | 2009 | 15 | |
| 17 | Second Generation Drugs-derivatives of Natural Antitumor Anthracycline Antibiotics Daunorubicin, Doxorubicin and Carminomycin | 2006 | 12 |
| 18 | 2005 | 11 | |
| 19 | 2004 | 6 | |
| 20 | 2003 | 18 |
About Anna N. Tevyashova
Anna N. Tevyashova is a scholar working on Toxicology, Molecular Medicine and Pharmacology, having authored 50 papers that have together received 602 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (16 papers), Bioactive Compounds and Antitumor Agents (8 papers), Microbial Natural Products and Biosynthesis (8 papers), Synthesis and Biological Evaluation (8 papers), Antifungal resistance and susceptibility (8 papers), Antibiotic Resistance in Bacteria (8 papers), DNA and Nucleic Acid Chemistry (5 papers) and RNA and protein synthesis mechanisms (5 papers). The work is most often cited by research in Molecular Medicine (70 citations), Toxicology (34 citations) and Pharmacology (160 citations). Anna N. Tevyashova has collaborated with scholars based in Russia, United Kingdom and Germany. Frequent co-authors include Eugenia N. Olsufyeva, M. N. Preobrazhenskaya, Аlexander А. Shtil, Elena P. Mirchink, Elena B. Isakova, Svetlana E. Solovieva, Lyubov G. Dezhenkova, Andrey E. Shchekotikhin, Svetlana S. Efimova and Э. Р. Переверзева. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.